Predatory drug pricing needs targeted legislation, enforcement, US DOJ, FTC told
Federal Trade Commission and US Department of Justice antitrust enforcers heard from pharmaceutical industry stakeholders today on the need for enforcement and legislation targeting high drug prices and reform in drug...To view the full article, register now.
Already a subscriber? Click here to view full article